Biomarkers refer to biochemical indicators that can mark changes in the structure or function of systems, organs, tissues, cells, and subcellular cells. Biomarkers can reflect normal physiological or pathological processes or drug responses to therapeutic interventions. It plays a role in early diagnosis, disease prevention, drug target determination, drug response, and other aspects. Biomarkers can use alone or in combination with other factors to assess the health or disease state of an individual. Digital biomarkers use to collect data from physiological or therapeutic methods and transform the new data into actionable insights and provide relevant information to the researchers for their better understanding of the disease.
The global digital biomarkers and biomarkers market to anticipate the market growth at a tremendous CAGR in the forecast period from 2020-2027. Due to the transformation of technology in the medical industry, reduce the risk of chronic diseases, accuracy in collecting data, and measured clinical insights are deriving the market of the digital biomarkers and biomarkers.
Whereas, biomarkers have an extensive range of uses and can be used to diagnose diseases, determine the stage of the disease, and evaluate the safety and effectiveness of new drugs or treatments in target populations. For disease research, biomarkers generally refer to a characteristic biochemical indicator in the normal physiological or pathological or therapeutic process that can be objectively measured and evaluated.
Moreover, With the adoption of smartphones, the Internet of things, cloud services, and other digital tools have increased the market share of digital biomarkers in the global market. The digital biomarkers help in gathering data of the patient through smartphones. Now, most of the physicians can track their patient’s blood pressure, heart rate, sleep cycle, and others with one single health app in their smartphones. The apps keep the record of the patient body function, and with sensors, it responds in case of any abnormality.
Additionally, the data collected from the app helps in interpreting the reports and health status of the patient and also provides accurate data to the clinicians for drawing up in the decision-making process. Moreover, digital biomarkers and markers are a very convenient, cost-effective, and engaging process for the patient.
Furthermore, with rising urbanization, people lifestyle has changed and coupled with a growing economy, disposable income has also increased. People have started focusing more on their health and fitness routines. Thus, digital biomarkers are the breakthrough in medical history for providing medical assistance to any person in a cost-effective manner and also reduce the chances of many severe diseases.
Digital biomarkers use to collect information and interpret the information to the researcher for a better understanding of both the health of the patient and disease. The adoption of smartphones in the world has fueled the demand for the digital biomarkers as it helps in collecting data of an individual through a healthcare app. The smart alarm or sensors installed in the app allow the individual to keep check of its daily routine and maintain a healthy lifestyle.
Biomarkers include early diagnosis or prognostic markers of the disease. Such biomarkers are currently the most widely used and have the most impact, and people are most familiar with them. It can see that biomarkers cover a wide range, and with the advancement of detection technology, more specific detection results as well.
Based on product, the global digital biomarkers and biomarkers market bifurcated into Consumables, Service. The service segment gains the largest market share in the global digital biomarkers market. As digital biomarkers account for a larger share in the market and digital biomarkers collect the data from the digital means by taking measures from behavioral, physiological, quantifiable. Thus, smartphones help digital biomarkers help in providing services to the patient. Moreover, in traditional biomarkers, consumables hold the largest market share owing to, low price of consumables and rising market demand.
Based on Type, the global digital biomarkers and biomarkers market distributed into Biomarkers-Safety, Efficacy, Validation, and Digital biomarkers- longitudinal, continuous measurement. The efficacy dominated the market value for the biomarkers in the market owing to, rising adoption of biomarkers, a wide variety of products available in the market. Moreover, digital biomarkers account for longitudinal measurement, which captures the largest share in the market. Due to its low cost, easy to use, non-invasive instruments, produce extensive and accurate data helps in fueling the market share of the digital biomarkers.
Based on the disease indication, the global digital biomarkers and biomarkers market bifurcated into Cancer, Cardiovascular Disorders. Cancer has captured the largest market share for the biomarkers in the disease indication market. Biomarkers use for diagnosis of cancer; thus, biomarkers application has been increasing in treating cancer. Moreover, the cardiovascular segment holds the largest share in digital biomarkers; it is mainly due to AR/VR adoption, and development helps in the detection of chronic pain.
Based on the Application, the global digital biomarkers and biomarkers market classified into Diagnostics Development, Drug Discovery and Development, Disease-Risk. Diagnostics development has the largest market share in the global digital biomarkers and biomarkers market. The main factors driving growth in this area include personalized and custom-designed treatment for various diseases like cancer and cardiovascular diseases, and neurological disorders have fueled the demand for the digital biomarkers and biomarkers in the global market.
Based on geography, the global digital biomarkers and biomarkers market size segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. The Asia Pacific expected to witness the highest growth during the forecast period. The growing demand for immediate diagnostic testing, changing lifestyle of the people, technology advancement, adoption of smartphone, growing geriatric population. Therefore, these factors will drive the growth of digital biomarkers and biomarkers in the Asia Pacific.
Companies such as Qiagen N.V., Perkinelmer, Inc., Merck Millipore, Bio-Rad Laboratories, Inc., Enzo Biochem, Inc., EKF Diagnostics Holdings, Inc., Meso Scale Diagnostics, LLC., Biosims Technologies Sas, Cisbio Bioassays, Signosis, Inc.other key players in the global Digital Biomarkers and biomarkers market.
|Market size value in 2020||USD 770.23 Million|
|Revenue forecast in 2027||USD 11.32 Billion|
|Growth Rate||CAGR of 38.45% from 2020 to 2027|
|Forecast period||2021 – 2027|
|Region covered||North America, Europe, Asia-Pacific, South America, and Middle East & Africa|
|Key companies Profiled||Qiagen NV, Enzo Biochem, Inc., Perkinelmer, Inc., Merck Millipore, Bio-Rad |
Laboratories, Inc., EKF Diagnostics Holdings, Inc., Meso Scale Diagnostics, LLC.,
Biosims Technologies Sas, Cisbio Bioassays, Signosis, Inc.
By Disease Indication
Biomarkers are biological state measures that can mark changes in the structure or function of systems, organs, tissues, cells, and subcellular cells.
The calculated Digital Biomarkers and Biomarkers market value is USD 770.23 Million in 2020 and will reach USD 11.32 Billion by 2027.
The growth rate of the Digital Biomarkers and Biomarkers market is 38.45% during the forecast period.
Biomarkers awareness among people, Adoption of Smartphones are the driving forces of the Digital Biomarkers and Biomarkers market.
By Application, the Digital Biomarkers and Biomarkers market is classified as Diagnostics Development, Drug Discovery and Development, Disease-Risk.